The eosinophilia-myalgia syndrome: the Los Alamos Conference.
On June 12 and 13, 1990 the Los Alamos National Laboratory in cooperation with the New Mexico Department of Health and Environment, the Centers for Disease Control (CDC), the Food and Drug Administration (FDA), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) hosted a conference on the eosinophilia-myalgia syndrome. Fifty presentations covered a variety of important issues which are summarized herein.
Hertzman
P A
PA
Los Alamos Medical Center, NM 87544.
Falk
H
H
Kilbourne
E M
EM
Page
S
S
Shulman
L E
LE
D002487:Centers for Disease Control and Prevention, U.S.; D004802:Eosinophilia / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology; D006801:Humans; D009316:National Institutes of Health (U.S.); D009516:New Mexico / Q000453:epidemiology; D011000:Pleurodynia, Epidemic / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology; D013577:Syndrome; D014481:United States; D014486:United States Food and Drug Administration